Jazz Pharmaceuticals’ Vyxeos now is approved for the treatment of secondary acute myeloid leukemia in pediatric patients.

An FDA advisory panel recommended Thursday, in a vote of 19-1, against approving Pfizer's experimental drug for the treatment of mild to moderate knee and hip pain.

Telehealth has been a welcomed service for both patients and health care providers during the COVID-19 pandemic, but a new study published in the American Journal of Preventive Medicine found that these services were mostly accessed by those living in affluent and metropolitan areas.

FDA has approved idecabtagene vicleuce (Abecma—Celgene), a cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy. It is the first cell-based gene therapy approved by FDA for the treatment of multiple myeloma.

With the country on the cusp of a potential fourth surge in coronavirus infections, President Biden on Monday urged state officials to reinstate masking requirements. "This is not politics," he said.

It is well established that long-term use of high doses of NSAIDs can cause kidney injury, especially in older adults. This association has been criticized, however, because it is based only on serum creatinine-based glomerular filtration rate (GFR) estimates.